The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-18
SponsorLena Xiao
About this trial
Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep.
Studying how insomnia affects PAP adherence in children can help improve future treatments.
However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.
Eligibility criteria
Qualifiers
Children aged 8-18 years old
Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG)
Newly prescribed PAP therapy
Disqualifiers
None
Trial design
Treatments tested in this trial
- Positive airway pressure therapy
Treatment groups
82 Participants
are divided into 1 treatment groupSponsors and collaborators
Lena Xiao
Lead sponsor
University of British Columbia
Sponsor institution
American Academy of Sleep Medicine
Collaborator
The Hospital for Sick Children
Collaborator
Source ClinicalTrials.gov